Home > Qtrly Results > INDOCO REMEDIES

INDOCO REMEDIES
Quarterly Results Analysis [Mar2026]

INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹476 Cr ₹445 Cr ₹485 Cr ₹438 Cr ₹390 Cr ₹411 Cr ₹433 Cr ₹431 Cr
Expenses ₹426 Cr ₹414 Cr ₹442 Cr ₹420 Cr ₹391 Cr ₹399 Cr ₹392 Cr ₹384 Cr
Operating Income ₹50 Cr ₹32 Cr ₹43 Cr ₹18 Cr ₹-1 Cr ₹12 Cr ₹40 Cr ₹48 Cr
Other Income ₹0 Cr ₹1 Cr ₹1 Cr ₹2 Cr ₹2 Cr ₹1 Cr ₹2 Cr ₹1 Cr
Interest ₹46 Cr ₹26 Cr ₹25 Cr ₹26 Cr ₹18 Cr ₹16 Cr ₹18 Cr ₹14 Cr
Depreciation ₹32 Cr ₹32 Cr ₹32 Cr ₹30 Cr ₹29 Cr ₹29 Cr ₹29 Cr ₹28 Cr
Profit Before Tax ₹-25 Cr ₹-31 Cr ₹-14 Cr ₹-37 Cr ₹-46 Cr ₹-31 Cr ₹-5 Cr ₹7 Cr
Profit After Tax ₹-24 Cr ₹-29 Cr ₹-9 Cr ₹-36 Cr ₹-41 Cr ₹-28 Cr ₹-10 Cr ₹2 Cr
EPS ₹-2.34 ₹-3.23 ₹-0.86 ₹-3.88 ₹-4.38 ₹-2.86 ₹-1.04 ₹0.29
Industry Peers & Returns1W1M1Y
INDOCO REMEDIES -7.2% -7% -21.8%
SUN PHARMACEUTICAL INDUSTRIES -3.2% 10.5% 9.3%
DIVIS LABORATORIES 0.8% 9.5% 4.2%
TORRENT PHARMACEUTICALS 2% 9.9% 35.4%
CIPLA -1.9% 13.3% -6%
DR REDDYS LABORATORIES -1.8% 7.4% 8.2%
MANKIND PHARMA -0.6% 11% -1.8%
LUPIN 1.2% -1.2% 12.7%
ZYDUS LIFESCIENCES 4.8% 11.8% 13.7%

INDOCO REMEDIES Quarterly Revenues

Revenues
Q-o-Q

6.79 %

Y-o-Y

21.89 %

Quarters Revenues % Change
Mar2026 ₹476 Cr
6.79
Dec2025 ₹445 Cr
-8.11
Sep2025 ₹485 Cr
10.68
Jun2025 ₹438 Cr
12.22
Mar2025 ₹390 Cr
-4.95
Dec2024 ₹411 Cr
-5.11
Sep2024 ₹433 Cr
0.27
Jun2024 ₹431 Cr -

INDOCO REMEDIES Quarterly Operating Profit

Operating Profit
Q-o-Q

57.76 %

Y-o-Y

Positive

Quarters Operating Profit % Change
Mar2026 ₹50 Cr
57.76
Dec2025 ₹32 Cr
-26.81
Sep2025 ₹43 Cr
145.58
Jun2025 ₹18 Cr
Positive
Mar2025 ₹-1 Cr
Negative
Dec2024 ₹12 Cr
-70.11
Sep2024 ₹40 Cr
-15.74
Jun2024 ₹48 Cr -
Operating Margins
Q-o-Q

47.60 %

Y-o-Y

Positive

Quarters Operating Margin% % Change
Mar2026 10.45%
47.60
Dec2025 7.08%
-20.27
Sep2025 8.88%
122.00
Jun2025 4%
Positive
Mar2025 -0.2%
Negative
Dec2024 2.93%
-68.49
Sep2024 9.3%
-15.99
Jun2024 11.07% -

INDOCO REMEDIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Mar2026 ₹-24 Cr
Negative
Dec2025 ₹-29 Cr
Negative
Sep2025 ₹-9 Cr
Negative
Jun2025 ₹-36 Cr
Negative
Mar2025 ₹-41 Cr
Negative
Dec2024 ₹-28 Cr
Negative
Sep2024 ₹-10 Cr
Negative
Jun2024 ₹2 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Mar2026 -4.98 %
Negative
Dec2025 -6.61 %
Negative
Sep2025 -1.9 %
Negative
Jun2025 -8.3 %
Negative
Mar2025 -10.59 %
Negative
Dec2024 -6.92 %
Negative
Sep2024 -2.31 %
Negative
Jun2024 0.42 % -

INDOCO REMEDIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Mar2026 ₹-2.34
Negative
Dec2025 ₹-3.23
Negative
Sep2025 ₹-0.86
Negative
Jun2025 ₹-3.88
Negative
Mar2025 ₹-4.38
Negative
Dec2024 ₹-2.86
Negative
Sep2024 ₹-1.04
Negative
Jun2024 ₹0.29 -

You may also like the below Video Courses